{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:01:09Z","timestamp":1788879669231,"version":"build-2803163510"},"reference-count":57,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa de Minas Gerais-FAPEMIG","doi-asserted-by":"publisher","award":["APQ-02564-22"],"award-info":[{"award-number":["APQ-02564-22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa de Minas Gerais-FAPEMIG","doi-asserted-by":"publisher","award":["RED-059-2023"],"award-info":[{"award-number":["RED-059-2023"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa de Minas Gerais-FAPEMIG","doi-asserted-by":"publisher","award":["424169\/2021-5"],"award-info":[{"award-number":["424169\/2021-5"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico-CNPq-Announcement RHAE","award":["APQ-02564-22"],"award-info":[{"award-number":["APQ-02564-22"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico-CNPq-Announcement RHAE","award":["RED-059-2023"],"award-info":[{"award-number":["RED-059-2023"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico-CNPq-Announcement RHAE","award":["424169\/2021-5"],"award-info":[{"award-number":["424169\/2021-5"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy, often diagnosed at an advanced stage due to its asymptomatic progression. The high recurrence rate and development of platinum-based chemotherapy resistance contribute to its poor prognosis. Despite advancements in molecular profiling, predictive biomarkers for chemotherapy response and recurrence risk remain limited. In this study, we developed OvarianTag\u2122, a biomarker panel integrating apoptosis and necroptosis pathways, to predict chemotherapy benefit and disease progression in EOC patients. This observational study was conducted in two phases. In the first phase, 45 patients were recruited, and RNA was extracted from fresh ovarian tissues (normal, benign, and malignant). qRT-PCR was performed to assess the relative expression of genes involved in apoptosis and necroptosis-regulated cell death pathways. Machine learning algorithms were applied to identify the relevant prognostic markers, leading to the development of OvarianTag\u2122. In the second phase, 55 additional EOC patients were included, and their formalin-fixed, paraffin-embedded (FFPE) tumor samples were analyzed using qRT-PCR. The classifier algorithm incorporated hierarchical clustering to stratify patients based on gene expression profiles. Significant differences in TNFRSF10C\/TRAIL-R3, TNFRSF10B\/TRAIL-R2, and CASP8 expression levels were observed between patient groups. CASP8 downregulation was strongly correlated with platinum resistance and a poor prognosis. Decision tree models achieved 83.3% accuracy in predicting platinum response and 79.2% accuracy in recurrence risk stratification. The OvarianTag\u2122 classifier demonstrated high sensitivity and specificity in identifying high-risk patients, supporting its potential as a prognostic tool. The OvarianTag\u2122 panel provides a novel approach for risk stratification in EOC, integrating apoptosis and necroptosis pathways to refine chemotherapy response prediction and recurrence risk assessment. This molecular assay has the potential to guide personalized treatment strategies, enhancing clinical decision-making and improving patient outcomes. Further validation in independent cohorts is warranted to establish its clinical utility.<\/jats:p>","DOI":"10.3390\/ijms26178393","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:42:21Z","timestamp":1756485741000},"page":"8393","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The OvarianTag\u2122 Biomarker Panel Emerges as a Prognostic Tool to Guide Clinical Decisions in Cisplatin-Based Treatment of Epithelial Ovarian Cancer"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-9410","authenticated-orcid":false,"given":"Let\u00edcia da Concei\u00e7\u00e3o","family":"Braga","sequence":"first","affiliation":[{"name":"Oncotag Desenvolvimento de Produtos e Servicos Para Sa\u00fade HumanaRua Tiradentes, 2689, Sala 102, Industrial, Contagem 32230-020, MG, Brazil"},{"name":"Laborat\u00f3rio de Pesquisa Translacional em Oncologia, N\u00facleo de Ensino, Pesquisa e Inova\u00e7\u00e3o, Instituto M\u00e1rio Penna, Belo Horizonte 30380-420, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4681-5451","authenticated-orcid":false,"given":"Laurence Rodrigues do","family":"Amaral","sequence":"additional","affiliation":[{"name":"Universidade Federal de Uberl\u00e2ndia, Campus Patos de Minas, Patos de Minas 38702-178, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Henrique","family":"Villar Delfino","sequence":"additional","affiliation":[{"name":"Oncotag Desenvolvimento de Produtos e Servicos Para Sa\u00fade HumanaRua Tiradentes, 2689, Sala 102, Industrial, Contagem 32230-020, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nara Rosana","family":"Andrade","sequence":"additional","affiliation":[{"name":"Oncotag Desenvolvimento de Produtos e Servicos Para Sa\u00fade HumanaRua Tiradentes, 2689, Sala 102, Industrial, Contagem 32230-020, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Guilherme","family":"de Oliveira Salles","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Pesquisa Translacional em Oncologia, N\u00facleo de Ensino, Pesquisa e Inova\u00e7\u00e3o, Instituto M\u00e1rio Penna, Belo Horizonte 30380-420, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-7861","authenticated-orcid":false,"given":"Agnaldo Lopes","family":"da Silva Filho","sequence":"additional","affiliation":[{"name":"Departamento de Ginecologia e Obstetr\u00edcia, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-564X","authenticated-orcid":false,"given":"Pedro Luiz Lima","family":"Bertarini","sequence":"additional","affiliation":[{"name":"Universidade Federal de Uberl\u00e2ndia, Campus Patos de Minas, Patos de Minas 38702-178, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula \u00c1lvares","family":"da Silva Ramos","sequence":"additional","affiliation":[{"name":"Oncotag Desenvolvimento de Produtos e Servicos Para Sa\u00fade HumanaRua Tiradentes, 2689, Sala 102, Industrial, Contagem 32230-020, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus de Souza","family":"Gomes","sequence":"additional","affiliation":[{"name":"Universidade Federal de Uberl\u00e2ndia, Campus Patos de Minas, Patos de Minas 38702-178, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Maria","family":"Silva Lopes","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Biologia Celular, Diretoria de Pesquisa e Desenvolvimento, Funda\u00e7\u00e3o Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian Cancer in the World: Epidemiology and Risk Factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int. J. Womens Health"},{"key":"ref_3","unstructured":"(2025, February 10). Neoplasia Maligna Do Corpo Do \u00datero e Do Ov\u00e1rio (Taxas Ajustadas)\u2014Instituto Nacional de C\u00e2ncer\u2014INCA, Available online: https:\/\/www.gov.br\/inca\/pt-br\/assuntos\/cancer\/numeros\/estimativa\/por-neoplasia-taxas-ajustadas\/corpo-utero-ovario."},{"key":"ref_4","unstructured":"(2023, October 08). Ovary Statistics|American Cancer Society\u2014Cancer Facts & Statistics. Available online: https:\/\/cancerstatisticscenter.cancer.org\/#!\/cancer-site\/Ovary."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the Ovary, Fallopian Tube, and Peritoneum: 2021 Update","volume":"155","author":"Berek","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11912-019-0816-0","article-title":"Novel Approaches to Ovarian Cancer Screening","volume":"21","author":"Nebgen","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijgo.14969","article-title":"Molecular Subtypes of Endometrial Cancer: Implications for Adjuvant Treatment Strategies","volume":"164","author":"Yang","year":"2024","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global Epidemiology of Epithelial Ovarian Cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_9","first-page":"284","article-title":"Ovarian Cancer Statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_11","first-page":"151","article-title":"Pathogenesis of Ovarian Cancer: Lessons from Morphology and Molecular Biology and Their Clinical Implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and Translational Advances in Ovarian Cancer Therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1470-2045(14)70049-X","article-title":"Carboplatin plus Paclitaxel Once a Week versus Every 3 Weeks in Patients with Advanced Ovarian Cancer (MITO-7): A Randomised, Multicentre, Open-Label, Phase 3 Trial","volume":"15","author":"Pignata","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in Ovarian Cancer Therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.critrevonc.2013.08.017","article-title":"Sensitivity and Resistance to Treatment in the Primary Management of Epithelial Ovarian Cancer","volume":"89","author":"Colombo","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gebhart, P., Singer, C., and Gschwantler-Kaulich, D. (2023). CA125 Levels in BRCA Mutation Carriers\u2014A Retrospective Single Center Cohort Study. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11116-6"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/IGC.0000000000000586","article-title":"Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers","volume":"26","author":"Duffy","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jnci\/djs177","article-title":"A DNA Repair Pathway-Focused Score for Prediction of Outcomes in Ovarian Cancer Treated with Platinum-Based Chemotherapy","volume":"104","author":"Kang","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Qin, Y., Sheng, Y., Ren, M., Hou, Z., Xiao, L., and Chen, R. (2024). Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61849-y"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy","volume":"18","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Li, Y., Gong, X., Hu, T., and Chen, Y. (2022). Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis. BMC Cancer, 22.","DOI":"10.1186\/s12885-021-09166-9"},{"key":"ref_22","first-page":"229","article-title":"Prediction of Chemoresistance\u2014How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer","volume":"31","author":"Paradowska","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ygyno.2012.04.038","article-title":"TRAIL-R3-Related Apoptosis: Epigenetic and Expression Analyses in Women with Ovarian Neoplasia","volume":"126","author":"Braga","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00404-013-3060-0","article-title":"Epigenetic and Expression Analysis of TRAIL-R2 and BCL2: On the TRAIL to Knowledge of Apoptosis in Ovarian Tumors","volume":"289","author":"Silva","year":"2014","journal-title":"Arch. Gynecol. Obs."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biopha.2013.12.004","article-title":"Single CpG Island Methylation Is Not Sufficient to Maintain the Silenced Expression of CASPASE-8 Apoptosis-Related Gene among Women with Epithelial Ovarian Cancer","volume":"68","author":"Silva","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"ref_26","first-page":"235","article-title":"C4.5: Programs for Machine Learning by J. Ross Quinlan. Morgan Kaufmann Publishers, Inc., 1993","volume":"16","author":"Salzberg","year":"1994","journal-title":"Mach. Learn."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Frank, E., Hall, M., Holmes, G., Kirkby, R., Pfahringer, B., Witten, I.H., and Trigg, L. (2009). Weka\u2014A Machine Learning Workbench for Data Mining. Data Mining and Knowledge Discovery Handbook, Springer.","DOI":"10.1007\/978-0-387-09823-4_66"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kuroki, L., and Guntupalli, S.R. (2020). Treatment of Epithelial Ovarian Cancer. BMJ, 371.","DOI":"10.1136\/bmj.m3773"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian Cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1200\/JCO.2016.68.1239","article-title":"Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer","volume":"34","author":"Meyer","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhang, M., Cheng, S., Jin, Y., Zhao, Y., and Wang, Y. (2021). Roles of CA125 in Diagnosis, Prediction, and Oncogenesis of Ovarian Cancer. Biochim. Biophys. Acta Rev. Cancer, 1875.","DOI":"10.1016\/j.bbcan.2021.188503"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-030-34025-4_18","article-title":"Ovarian Cancer Biomarkers: Moving Forward in Early Detection","volume":"1219","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Damia, G., and Broggini, M. (2019). Platinum Resistance in Ovarian Cancer: Role of DNA Repair. Cancers, 11.","DOI":"10.3390\/cancers11010119"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A Review of Programmed Cell Death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biocel.2007.02.007","article-title":"TRAIL Signalling: Decisions between Life and Death","volume":"39","author":"Falschlehner","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dai, X., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M.E., Alharbi, S.A., Kumar, A.P., Ahn, K.S., and Sethi, G. (2015). Targeting TNF-Related Apoptosis-Inducing Ligand (TRAIL) Receptor by Natural Products as a Potential Therapeutic Approach for Cancer Therapy. Exp. Biol. Med., 240.","DOI":"10.1177\/1535370215579167"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs Less Travelled: TRAIL in Cancer Biology and Therapy","volume":"17","author":"Montinaro","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.bmcl.2019.07.053","article-title":"Targeting TRAIL","volume":"29","author":"Ion","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ygyno.2003.11.054","article-title":"Chemotherapy Induces Death Receptor 5 in Epithelial Ovarian Carcinoma","volume":"92","author":"Arts","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119525","DOI":"10.1016\/j.lfs.2021.119525","article-title":"Oleuropein Reduces Cisplatin Resistance in Ovarian Cancer by Targeting Apoptotic Pathway Regulators","volume":"278","author":"Rahmati","year":"2021","journal-title":"Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5483\/BMBRep.2018.51.5.074","article-title":"The Role of Necroptosis in the Treatment of Diseases","volume":"51","author":"Cho","year":"2018","journal-title":"BMB Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1073\/pnas.1901179116","article-title":"Targeting RIPK1 for the Treatment of Human Diseases","volume":"116","author":"Degterev","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.critrevonc.2011.08.004","article-title":"Necroptosis: An Emerging Form of Programmed Cell Death","volume":"82","author":"Wu","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hou, J., Ju, J., Zhang, Z., Zhao, C., Li, Z., Zheng, J., Sheng, T., Zhang, H., Hu, L., and Yu, X. (2019). Discovery of Potent Necroptosis Inhibitors Targeting RIPK1 Kinase Activity for the Treatment of Inflammatory Disorder and Cancer Metastasis. Cell Death Dis., 10.","DOI":"10.1038\/s41419-019-1735-6"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40291-020-00482-7","article-title":"Oncotype DX Breast Recurrence Score\u00ae: A Review of Its Use in Early-Stage Breast Cancer","volume":"24","author":"Syed","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/fon-2018-0221","article-title":"MammaprintTM: A Comprehensive Review","volume":"15","year":"2019","journal-title":"Future Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhang, R., Siu, M.K.Y., Ngan, H.Y.S., and Chan, K.K.L. (2022). Molecular Biomarkers for the Early Detection of Ovarian Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231912041"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.6061\/clinics\/2012(05)06","article-title":"A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses","volume":"67","author":"Anton","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG Inhibitors in Cancer Treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/1574892813666180305165256","article-title":"PARP Inhibitors in Ovarian Cancer","volume":"13","author":"Mittica","year":"2018","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00018-018-2958-x","article-title":"Induction of Apoptosis in Ovarian Cancer Cells by MiR-493-3p Directly Targeting AKT2, STK38L, HMGA2, ETS1 and E2F5","volume":"76","author":"Kleemann","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00005-014-0307-9","article-title":"Restoring TRAIL Mediated Signaling in Ovarian Cancer Cells","volume":"62","author":"Farooqi","year":"2014","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ijgo.12608","article-title":"FIGO Cancer Report 2018","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_56","unstructured":"(2025, February 10). R: The R Project for Statistical Computing. Available online: https:\/\/www.r-project.org\/."},{"key":"ref_57","unstructured":"Haykin, S. (2001). Redes Neurais: Princ\u00edpios e Pr\u00e1tica\u2014Simon Haykin\u2014Google Livros, Bookman Editora."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8393\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:06Z","timestamp":1760034906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":57,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178393"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178393","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}